Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Kron A et al …
この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Kron A et al …
この記事を読む
Predicting survival following surgical resection of lung cancer using clinical and pathological variables: The developme…
この記事を読む
Assessment of Resistance Mechanisms and Clinical Implications in Patients With EGFR T790M-Positive Lung Cancer and Acqui…
この記事を読む
Three new disease-progression modes in NSCLC patients after EGFR-TKI treatment by next-generation sequencing analysis We…
この記事を読む
Characterization of Computed Tomography Imaging of Rearranged During Transfection-rearranged Lung Cancer. Saiki M et al.…
この記事を読む
Long-Term Active Surveillance of Screening Detected Subsolid Nodules is a Safe Strategy to Reduce Overtreatment. Silva M…
この記事を読む
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. Horn L et al. N Engl J Med. 2018 Se…
この記事を読む
Hyperprogressive Disease in Patients With Advanced Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors or With…
この記事を読む
Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With E…
この記事を読む
Computed tomography characteristics of lung adenocarcinomas with epidermal growth factor receptor mutation: A propensity…